Several proposals to make coverage more accessible and affordable for millions of Californians were left out of the state’s 2018-19 budget, dealing a sharp setback to Democratic lawmakers who fashion themselves as leaders of the resistance against federal retrenchment on health care. By Ana B. […]
In a move that sounds reasonable, but will continue the catastrophic cutbacks to healthcare access, the Department of Labor released a new rule this week governing Association Health Plans, or AHPs. Small business can band together, allowing them to easily form groups based on geography or […]
At a U.S. Senate Health Committee hearing this week, a top administration official tried to say that the decision by the Department of Justice to undo health insurance protections for people with pre-existing conditions had nothing to do with the president’s campaign to rein in […]
52 million Americans could be affected by the latest healthcare tripwire purposefully set off by the Trump administration, which is declining to support certain mandates that include protections for pre-existing conditions. In 2016, a Kaiser Family Foundation study estimated that 27 percent of adult Americans […]
California Attorney General Xavier Becerra pledged Friday to redouble his efforts as the Affordable Care Act’s leading defender, saying attacks by the Trump Administration threaten health care for millions of Americans. Becerra’s pledge came in response to an announcement from the administration Thursday that it would […]
Nationwide, 83 of 2,375 rural hospitals have closed since 2010. These often-remote hospitals — some with 10, 15, 25 beds — have been targeted by management companies or potential buyers who promise much but often deliver little while lining their own pockets. Barbara Feder Ostrov, […]
In our top stories this week, we have a generic drug pricing scam, Germany beating the U.S. (and not in soccer) and a growing number of primary elections focused on candidates supporting Medicare for All. In a related article, doctor burnout because of uninsured patients […]
By delaying development of generics, drugmakers can maintain their monopolies and keep prices high. Most of the drugs cost Medicare Part D more in 2016 than they did in 2012, for an average spending increase of about 60 percent more per unit. This excludes drugs […]
